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INTRODUCTION
Keratoconus is a bilateral, progressive, non‑inflammatory 
ectatic corneal disease of unknown etiology which 
impairs visual function due to corneal thinning and 
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Abstract
Purpose: To evaluate long‑term follow‑up data on implantation of a full‑ring intra‑corneal implant (MyoRing) 
for management of keratoconus.
Methods: A total of 40 keratoconic eyes of 37 consecutive patients who had undergone MyoRing implantation 
using the Pocket Maker microkeratome (Dioptex, GmbH, Linz, Austria) and completed 3 years of follow‑up 
appointments were included in this retrospective study. Uncorrected distance visual acuity (UDVA), 
corrected distance visual acuity (CDVA), refraction and keratometry (K) readings were measured and 
evaluated preoperatively, and 3 years, postoperatively.
Results: No intraoperative complications were observed in this case series. Three years postoperatively, 
there was a significant improvement in UDVA, CDVA, K readings, spherical equivalent (SE), and manifest 
sphere and cylinder (P < 0.05 for all comparisons). UDVA was significantly improved from 1.14 ± 0.27 
to 0.30 ± 0.21 LogMAR (P = 0.001), CDVA was also improved from 0.52 ± 0.23 to 0.18 ± 0.12 LogMAR 
(P = 0.001), SE was decreased by 4.35 diopters (D) and average keratometric values were reduced by 2.34 
D (P = 0.001). Overall, 81% of subjects were moderately to highly satisfied 3 years after surgery and 64.90% 
agreed to have the fellow eye implanted with MyoRing.
Conclusion: MyoRing implantation using the Pocket Maker microkeratome was found to be a minimally 
invasive procedure for improving visual acuity and refraction in the majority of the patients with keratoconus.
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protrusion.[1‑3] Management of keratoconus includes 
spectacles,[1,4] contact lenses,[5] collagen crosslinking 
(CXL), [6] intracorneal ring segments (ICRSs),[7‑11] 
deep anterior lamellar keratoplasty, and penetrating 
keratoplasty (PK).[12‑14]
ICRSs play a pivotal role in the management of 
keratoconus by flattening the central cornea via 
an “arc‑shortening” effect on the corneal lamellae.
[15] However several complications, including 
non‑concentric tunnels and segment extrusion, as 
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well as the presence of perplexing nomograms limit 
the advantages of ICRSs.[16,17] Corneal intrastromal 
implantation system (CISIS) using the Pocket Maker 
microkeratome (Dioptex, GmbH, Linz, Austria) and the 
MyoRing intracorneal implant (Dioptex, GmbH, Linz, 
Austria) are a surgical option whereby a flexible full‑ring 
implant is inserted into a corneal pocket for treatment 
of keratoconus,[18,19] post‑LASIK keratectasia,[20] as well 
as moderate and high myopia.[21] MyoRing is a flexible, 
full‑ring polymethylmetacrylate (PMMA) intracorneal 
implant, available in diameters ranging from 5 to 6 
mm and thickness ranging from 200 to 400 μm in 20 
μm increments. The anterior surface is convex, and the 
posterior surface is concave, with a radius of curvature 
of 8.00 mm.[21]
Reports on long‑term outcomes and late complications 
of implantation of this type of intrastromal implants 
are scarce. The present study evaluates the visual and 
refractive outcomes of MyoRing implantation in eyes 
with keratoconus using the mechanical Pocket Maker 
microkeratome technology. We included keratoconic 
patients who had completed at least three years of 
follow‑up examinations.
METHODS
Of 65 patients (69 eyes) who had been operated during 
the study period, twenty patients (21 eyes) were unable to 
attend follow‑up appointments and were thus excluded 
from the study. Of the 44 patients (48 eyes) with complete 
follow‑up, seven patients (eight eyes) were excluded 
because of additional interventions including MyoRing 
removal or exchange, or DALK. A total of 37 patients 
(40 eyes) with moderate and severe keratoconus, aged 
18 and 45 years remained in this retrospective study.
All eyes had undergone (Dioptex, GmbH, Linz, Austria) 
implantation using the Pocket Maker microkeratome 
(Dioptex, GmbH, Linz, Austria) from October 2010 
to June 2011 at Bina Eye Hospital, Tehran, Iran. The 
Institutional Review Board of the Eye Research Center 
approved this study, and the tenets of the Declaration 
of Helsinki were followed.
Keratoconus diagnosis was based on corneal 
topography and slit lamp examination.[1] Inclusion 
criteria were keratoconic patients with no corneal scar, 
minimum corneal thickness of 360 microns, contact 
lens intolerance and uncorrected distance visual acuity 
(UDVA) worse than 20/50. Exclusion criteria for surgery 
were pregnancy, breast‑feeding, history of vernal and 
atopic keratoconjunctivitis, history of keratorefractive 
surgery in the scheduled eye, presence of dry eye, history 
of corneal stromal disorders, hyperopia and patients with 
other ocular and systemic comorbidities.
A comprehensive ophthalmic examination was 
performed pre‑ and postoperatively in all cases which 
included measurement of unorrected distance visual 
acuity (UDVA), corrected distance visual acuity 
(CDVA), manifest refraction (sphere and cylinder), 
ultrasonic pachymetry, fundus examination, slit lamp 
biomicroscopy and corneal topography.
The MyoRing dimensions were selected according 
to the MyoRing nomogram based on theoretical 
calculation derived from an experimental biomechanical 
corneal model.[22‑25] This nomogram takes into account 
mean central keratometry and corneal thickness at 
the thinnest point.[18] Orbscan II topography system 
(Bausch and Lomb) was used to evaluate the anterior and 
posterior corneal surfaces. Visual acuity was measured 
using the Snellen chart and then converted to logarithm 
of minimum angle of resolution (LogMAR) notations for 
statistical analysis.
All surgical procedures were performed by the same 
experienced surgeon (K.J.) under topical anesthesia. 
The central point of the site of intrastromal corneal 
ring implantation was marked under the operation 
microscope (OMS‑800 Standard, TOPCON Corporation, 
Japan). All procedures were performed with a temporal 
approach using self‑sealing incisions. A pocket was 
created in the 9‑mm central corneal at a depth of 
300 microns using a Pocket Maker microkeratome. 
Then, the Myoring was implanted into the corneal 
pocket.[19‑21] The position of the implant was adjusted 
intraoperatively using a handheld keratoscope [Figure 1]. 
At the conclusion of the operation, a bandage contact 
lens was placed on the cornea.
Postoperatively, all eyes were medicated with 
bethamethasone 0.1% eye drops (Sina Darou, Tehran, 
Iran) 4 times a day, chloramphenicol 0.5% eye drops (Sina 
Darou, Tehran, Iran) 4 times a day, and non‑preserved 
artificial tear (Artelac) (Baush and Lomb, France, 
SAS) 4 times a day. Chloramphenicol eye drops were 
discontinued 1 week postoperatively, and betamethasone 
eye drops were tapered off over 4‑6 weeks. Bandage 
contact lenses were removed on the first postoperative 
day.
Figure 1. MyoRing implant in a keratoconic eye.
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Safety of the procedure was assessed using a refractive 
surgery safety index given below:
Safety index = (postoperative CDVA)/(preoperative 
CDVA)
Efficacy of the procedure was assessed using a 
refractive surgery efficacy index given below:
Efficacy index = (postoperative UDVA)/(preoperative 
CDVA).[26,27]
Overall satisfaction was assessed using a 6‑point 
Likert scale: 0 ‑ no satisfaction, 1 ‑ very little satisfaction, 
2 ‑ little satisfaction, 3 ‑ moderate satisfaction, 4 ‑ much 
satisfaction, 5 ‑ very much satisfaction.
Statistical analysis was performed with SPSS software 
(IBM SPSS Statistics for Windows, Version 20.0. Armonk, 
NY: IBM Corp). Continuous variables are presented in 
mean and standard deviations while qualitative variables 
are reported in frequencies (percentages). The paired 
t‑test was used to compare pre‑and postoperative values 
including UDVA, CDVA, SE, maximum keratometry, 
minimum keratometry, and average keratometry. P values 
less than 0.05 were considered as statistically significant.
RESULTS
A total of 40 eyes of 37 patients with mean age of 28.2 ± 12 
(range 18 to 45) years, including 19 male (51.3%) and 
18 female (48.7%) subjects, were analyzed. UDVA and 
CDVA were improved significantly in all patients as 
compared to preoperative values [Table 1]. Mean UDVA 
was improved from 1.14 LogMAR preoperatively to 
0.30 LogMAR postoperatively (P < 0.001), and mean 
CDVA was improved from 0.52 to 0.18 LogMAR 
(P < 0.001). UDVA and CDVA were improved by 8 and 4 
Snellen lines, respectively [Figures 2 and 3]. The efficacy 
and safety indexes were 1.66 and 2.66, respectively at 
3 years postoperatively.
We observed a statistically significant reduction in 
mean spherical equivalent refractive error from − 6.53 D 
preoperatively to − 2.18 postoperatively (P < 0.001) [Table 1]. 
Additionally mean K reading was decreased by 2.34 D (from 
49.85 D to 47.51 D, P = 0.001) [Figures 3 and 4 and Table 1]. 
All patients were satisfied with MyoRing implantation. 
Likewise, on a scale of 0 to 5 for current overall satisfaction, 
81.0% of patients had moderate to high satisfaction with 
the operation (score 3‑5) [Table 2].
No major complications occurred in the reported 
group of 40 eyes. However, patient dissatisfaction led to 
additional procedures in eight eyes including MyoRing 
removal (1 eye), exchange (5 eyes) or deep anterior 
lamellar keratoplasty (2 eyes). Details of these patients 
are shown in Table 3.
DISCUSSION
To our knowledge, this series is the first to report 
3‑year follow‑up results of MyoRing implantation for 
keratoconus in a considerable number of patients. ICRSs 
have been shown to be safe and effective in correcting 
ectatic corneal disorder.[27,28] Nevertheless, segment 
extrusion, epithelial plug at the initial incision site, corneal 
neovascularization, segment migration, infectious 
keratitis, channel deposits, chronic pain, corneal haze, 
corneal melting, persistent incisional gaping, night halos 
and focal edema were reported as complications and 
limitations of ICRS implantation. Daxer et al[29] have 
shown that visual outcomes of MyoRing implantation 
Table 1. Pre‑ and post‑operative visual and refractive data
Variables Preoperative 
examination
3 years 
postoperative 
examination
P*
UDVA (LogMAR)
Mean (SD) 1.14 (0.27) 0.30 (0.21) <0.001
Range 0.40‑1.60 0.00‑1.0
CDVA (LogMAR)
Mean (SD) 0.52 (0.23) 0.18 (0.12) <0.001
Range 0.40‑1.30 0.00‑0.40
Sphere (D)
Mean (SD) −4.00 (3.64) −1.01 (2.20) <0.001
Range −14.00‑1.0 −7.00‑2.00
Cylinder (D)
Mean (SD) −5.05 (1.68) −2.07 (0.88) <0.001
Range −10.00‑−2.00 −6.00‑−0.50
Spherical 
equivalent (D)
Mean (SD) −6.53 (3.89) −2.18 (2.240) <0.001
Range −17.00‑−1.00 −8.50‑1.00
K max value (D)
Mean (SD) 52.73 (4.14) 49.24 (3.42) <0.001
Range 44.90‑64.40 42.00‑57.00
K min value (D)
Mean (SD) 47.11 (3.07) 45.79 (3.56) 0.006
Range 41.70‑54.50 39.00‑54.00
K mean value (D)
Mean (SD) 49.85 (3.45) 47.51 (3.35) <0.001
Range 44.10‑59.45 40.55‑54.80
UDVA, uncorrected distance visual acuity; CVDA, corrected 
distance visual acuity; LogMAR, logarithm minimum angle of the 
resolution; K, keratometry; Max, maximum; Min, minimum; SD, 
standard deviation; D, diopter, *Significances are based on Wilcoxon 
signed‑rank test
Table 2. Satisfaction scores after 3 years
Satisfaction score (n=37) Frequency (%) Mean (SD)
No 0.0 (0.0) 3.84 (1.26)
Very little 2.0 (5.5)
Little 5.0 (13.5)
Moderate 5.0 (13.5)
Much 10.0 (27)
Very much 15.0 (40.5)
SD, standard deviation; n, number
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for keratoconus does not depend on whether the corneal 
pocket is created by the femtosecond laser or mechanical 
dissection using the Pocket Maker microkeratome. In 
addition, no correlation was found between the type 
and location of the cone, and outcomes of MyoRing 
implantation.[30] In our study, the efficacy and safety 
index were above 1 at the last follow‑up. These results 
are in concordance with most similar studies reporting 
the outcomes of MyoRing implantation for myopia and 
keratoconus.[20,21,31]
In our study, the rate of MyoRing exchange and 
removal was 16.6% (8/48). Studies by Clinch et al,[32] 
and Asbell et al[33] reported a 6.87% and 4.7% rate of 
ICRS removal, respectively. MyoRing removal was not 
associated with loss of UDVA, induction of myopia or 
astigmatism in the current study [Table 3]. Our results 
are in agreement with studies with shorter follow‑up 
periods after MyoRing implantation[20,21,30,31]
Three years after surgery, significant reductions of 
3.0 D and 2.98 D were observed in sphere and cylinder, 
respectively. These levels of refractive changes are 
consistent with those previously reported after MyoRing 
implantation using mechanical dissection.[20,21,30,34] In the 
current series, mean improvement in UDVA and CDVA 
was equivalent to 8 and 4 Snellen lines, respectively, 
which is compatible with previous studies by Mahmood 
et al,[21] Daxer et al[20] and Mojaled Nobari et al[34] 
Compared to some other MyoRing studies, our results 
showed greater improvement in UDVA. Jabbarvand 
et al operated 95 keratoconic eyes and showed a mean 
Table 3. Clinical data in eyes requiring reoperation
Patient 
number (n=8)
Sex Age UDVA before 
operation
UDVA after 
operation
Intervention 1 Intervention 2 Last UDVA
1 Female 22 0.1 0.7 Ring exchange
After 2 years
Ring removal
(After 2 months)
0.4
2 Male 34 0.1 0.1 Ring exchange
After 1 year
‑ (CF) at 3 m
3 Female 25 0.05 CF at 1 m Ring change
After 6 months
DALK
After 1 year
0.1
4 Male 25 0.05 0.3 DALK
After 1 year
‑ 0.4
5 Female 28 0.1 0.6 Removal
After 6 months
Mayoring (Femto)
After 2 years
0.8
6 Male 23 0.1 0.1 Ring exchange
After 3 months
DALK
After 2 years
0.6
7 Female 29 0.05 0.2 DALK
After 1 year
‑ 0.2
8 Male 23 CF at 1 m 0.1 Ring exchange
After 3 months
‑ 0.2
UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity; DALK, deep anterior lamellar keratoplasty; CF, count 
finger; n, number; m, meter
Figure 2. Bar nomogram illustrates the percentage of eyes 
gaining lines of uncorrected distance visual acuity (UDVA) 3 
years after surgery.
Figure 3. Bar nomogram illustrates the percentage of eyes 
gaining lines of best spectacle corrected distance visual acuity 
(CDVA) 3 years after surgery.
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change of six lines.[35] Alio et al reported a mean change 
in UDVA from 1.36 to 0.61 LogMAR in 12 keratoconic 
eyes with MyoRing implantation.[36]
Mean improvement in UDVA in our study was more 
marked than those reported by studies on other ICRSs. 
Colin and Malet reported that UDVA was improved by 
five lines after Intacs implantation in 100 keratoconic 
eyes.[37] Shabayek and Alió found that UDVA was 
increased by six lines after KeraRing implantation in 21 
keratoconic eyes.[38] This difference can be explained by 
the fact that MyoRing implants have a greater potential 
for myopic and astigmatic correction in keratoconus than 
other ICRSs, probably because of the more significant 
arc‑shortening effect achieved with the completely 
circular mid‑peripheral design of the MyoRing implant.
Our study has potential limitations, including 
lacking evaluation of higher‑order aberration and a 
non‑homogeneous number of patients in each stage of 
keratoconus severity. Thus, it would be interesting to 
carry out prospective studies to assess the outcomes of 
this procedure in different stages of disease.
In summary, MyoRing implantation using the Pocket 
Maker is a minimally invasive procedure that provides 
favorable clinical outcomes in keratoconus. Additionally, 
MyoRing implantation is a reversible and adjustable 
surgical procedure. However, further randomized, 
multi‑centric prospective studies are needed to confirm 
the results of the current study.
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